U.S. Code of Federal Regulations
Regulations most recently checked for updates: Aug 28, 2025
(a) Specifications. Each tablet contains 5 milligrams (mg) trimeprazine tartrate and 2 mg prednisolone.
(b) Sponsors. See Nos. 054771 and 086117 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—(1) Amount. Administer orally an initial dosage: for dogs weighing up to 10 pounds,
(2) Indications for use. For the relief of itching regardless of cause; and for reduction of inflammation commonly associated with most skin disorders of dogs such as eczema, caused by internal disorders, otitis, and dermatitis, allergic, parasitic, pustular, and nonspecific origins. As adjunctive therapy in various cough conditions including treatment of “kennel cough” or tracheobronchitis, bronchitis including allergic bronchitis, infections, and coughs of nonspecific origin.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.